Medscape www.medscape.com

Tables for:
The Management of Cirrhotic Ascites

[Medscape General Medicine 4(4), 2002. © 2002 Medscape]


Table 1. Definitions of Refractory Ascites


Diuretic-resistant ascites:

Lack of response (weight loss < 200 g/day and urinary sodium
excretion < 50 mmol/day) on a 50-mmol sodium/day diet and maximal
doses of diuretics (spironolactone 400 mg/day and furosemide 160 mg/day
for 2 weeks).

Diuretic-intractable ascites:

Development of diuretic-induced complications such as severe electrolyte
disturbances, renal impairment, or hepatic encephalopathy, precluding the
use of an effective diuretic dose.



Table 2. Factors Predisposing to SBP


  • Severity of liver disease (70% of all SBP episodes are in patients with Child-Pugh class C cirrhosis)
  • Ascitic fluid total protein level of < 1 g/dL and/or ascitic fluid complement factor C3 < 13 mg/dL
  • Gastrointestinal bleeding
  • Urinary tract infections
  • Intestinal bacterial overgrowth
  • Iatrogenic sources of bacteremia such as urinary bladder and intravascular catheters
  • One or more previous SBP episodes
  • Serum bilirubin of > 2.5 mg/dL


Table 3. Symptoms and Signs of SBP


Fever

69%

Abdominal pain

59%

Hepatic encephalopathy

54%

Abdominal tenderness

49%

Diarrhea

32%

Ileus

30%

Shock

21%

Hypothermia

17%

Asymptomatic

10%



Table 4. Indications for Diagnostic Paracentesis in Hospitalized Patients With Ascites


At the beginning of each admission to hospital:

  • Symptoms or signs of peritoneal infection
  • -abdominal pain, rebound tenderness, vomiting, diarrhea, ileus

  • Systemic signs of infection
  • -fever, leukocytosis, septic shock

  • Hepatic encephalopathy or rapid impairment in renal function without clear precipitant

  • Gastrointestinal bleeding before starting prophylactic antibiotics

Table 5. Treatment Regimens for SBP


  • Cefotaxime 2 g intravenously every 12 hours x minimum of 5 days
  • Other cephalosporins (cefonicid, ceftriaxone, ceftizoxime, ceftazidime)
  • Amoxicillin (1 g) and clavulanic acid (200 mg) intravenously 3 times daily x ~5 days, then orally 500 mg/125 mg 3 times daily x ~3 days
  • Ciprofloxacin 200 mg intravenously every 12 hours x 7 days
  • Ciprofloxacin 200 mg intravenously every 12 hours x 2 days then 500 mg orally every 12 hours x 5 days


Table 6. Recommendations for SBP Prophylaxis


In nonbleeding cirrhotic patients with ascites:

  • Recovering from an SBP episode
  • -continuous oral administration of norfloxacin 400 mg daily or ciprofloxacin 750 mg weekly

    -consider liver transplantation

  • Without past history of SBP and with
  • -high ascitic fluid protein (> 10 g/dL): no prophylaxis necessary

    -low ascitic fluid protein (< 10 g/dL): no consensus on the necessity of prophylaxis

In cirrhotics with upper gastrointestinal hemorrhage:

  • Exclusion of SBP and other infections before prophylaxis

  • Oral administration of norfloxacin 400 mg every 12 hours x minimum of 7 days

  • Alternative regimens:

  • -ofloxacin 400 mg/day x 10 days (first intravenously, then orally) and with each endoscopy 1 g of amoxicillin/200 mg clavulanic acid

    -ciprofloxacin 500 mg twice daily x 7 days orally or via nasogastric tube after endoscopy

    -amoxicillin/clavulanic acid 1 g/200 mg 3 times daily and ciprofloxacin 200 mg twice daily intravenously then orally until 3 days after cessation of bleeding